Your browser doesn't support javascript.
loading
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China.
Zhang, Qingyuan; Shao, Zhimin; Shen, Kunwei; Li, Li; Feng, Jifeng; Tong, Zhongsheng; Gu, Kangsheng; Wang, Xiaojia; Xu, Binghe; Sun, Guofang; Chen, Huifang; Rukazenkov, Yuri; Jiang, Zefei.
Affiliation
  • Zhang Q; Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
  • Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Shen K; Shanghai Ruijin Hospital, Shanghai, China.
  • Li L; The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
  • Feng J; Jiangsu Cancer Hospital, Nanjing, Jiangsu, China.
  • Tong Z; Tianjin Cancer Hospital, Tianjin, China.
  • Gu K; The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Wang X; Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • Xu B; Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Sun G; AstraZeneca, Shanghai, China.
  • Chen H; AstraZeneca, Shanghai, China.
  • Rukazenkov Y; AstraZeneca, Macclesfield, UK.
  • Jiang Z; Hospital of Chinese People's Liberation Army, Beijing, China.
Oncotarget ; 7(35): 57301-57309, 2016 Aug 30.
Article in En | MEDLINE | ID: mdl-27359058
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Drug Administration Schedule / Antineoplastic Agents, Hormonal / Estrogen Receptor alpha / Estradiol Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Oncotarget Year: 2016 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Drug Administration Schedule / Antineoplastic Agents, Hormonal / Estrogen Receptor alpha / Estradiol Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Oncotarget Year: 2016 Document type: Article Affiliation country: China